MiMedx: Q4 Earnings Snapshot

February 28, 2022 GMT

MARIETTA, Ga. (AP) _ MiMedx Group Inc. (MDXG) on Monday reported fourth-quarter earnings of $618,000.

The Marietta, Georgia-based company said it had net income of 1 cent per share.

The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 3 cents per share.

The developer of biomaterials made from sterilized human amniotic membrane posted revenue of $67.4 million in the period, also surpassing Street forecasts. Three analysts surveyed by Zacks expected $63.5 million.

For the year, the company reported that its loss narrowed to $16.4 million, or 15 cents per share. Revenue was reported as $258.6 million.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MDXG at https://www.zacks.com/ap/MDXG